Thiohydantoin derivatives incorporating a pyrazole core: Design, synthesis and biological evaluation as dual inhibitors of topoisomerase-I and cycloxygenase-2 with anti-cancer and anti-inflammatory activities

This publication has 31 references indexed in Scilit:

• OSU-A9 inhibits angiogenesis in human umbilical vein endothelial cells via disrupting Akt–NF-κB and MAPK signaling pathways
  Toxicology and Applied Pharmacology, 2013
• The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: The second clinical candidate having a shorter and favorable human half-life
  Bioorganic & Medicinal Chemistry Letters, 2010
• Synthesis of new pyrazole derivatives and their anticancer evaluation
  European Journal of Medicinal Chemistry, 2010
• Promise and challenges in drug discovery and development of hybrid anticancer drugs
  Expert Opinion on Drug Discovery, 2009
• Pro-Inflammatory Enzymes, Cyclooxygenase 1, Cyclooxygenase 2, and 5-Lipooxygenase, Inhibited by Stabilized Rice Bran Extracts
  Journal of Medicinal Food, 2009
• Topoisomerase I inhibitors: camptothecins and beyond
  Nature Reviews Cancer, 2006
• Anticancer effect of three pyrazole derivatives
  Natural Product Research, 2006
• Celecoxib Inhibits Prostate Cancer Growth: Evidence of a Cyclooxygenase-2-Independent Mechanism
  Clinical Cancer Research, 2005
• Cellular roles of DNA topoisomerases: a molecular perspective
  Nature Reviews Molecular Cell Biology, 2002
• DNA Topoisomerases: Structure, Function, and Mechanism
  Annual Review of Biochemistry, 2001